Defying US and EU regulators, Illumina acquires cancer detection firm Grail - NewsBreak

San Diego sequencing giant Illumina announced Wednesday that it has acquired Bay Area cancer detection firm Grail, a move sure to rankle regulators in the U.S. and European Union fiercely opposed to the deal. Illumina first announced its $7.1 billion bid to buy Grail last September. The Menlo Park startup...